Ascend Laboratories, LLC recalls Rizatriptan Benzoate Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
- Products
-
- Rizatriptan Benzoate Tablets
- Company
- Ascend Laboratories, LLC
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- N/A
- About this recall
- Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ 07054, NDC 67877-262-18